Top 4 Highlights from Digestive Disease Week 2015
Check out NFCA's list of the top four highlights from Digestive Disease Week 2015.
x
Opt-in to stay up-to-date on the latest news.
Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease. To view all information related to drug development and research, please visit our main celiac disease research page. Learn about the Beyond Celiac Science Department here.
Check out NFCA's list of the top four highlights from Digestive Disease Week 2015.
Sanofi and Selecta Biosciences, Inc. collaborate on new immunotherapy for celiac disease.
The Jefferson Celiac Center is seeking participants for a research study.
Professor Detlef Schuppan, a member of the Beyond Celiac Research Summit Planning Committee, accepts the first international celiac disease prize awarded by the University of Tampere in Finland.
Tricia Thompson, MS, RD of Gluten-Free Watchdog answers common questions about arsenic in rice.
Company to develop AMG 714 for the treatment of diet non-responsive celiac disease and refractory celiac disease (celiac disease-triggered T-cell lymphoma).
New research on a screening method could improve the celiac disease diagnosis rate in children.
Emerging therapeutic company to initially focus on addressing the significant medical and socioeconomic needs of patients with celiac disease
Although more research is needed, larazotide acetate may work better than the gluten-free diet alone in some patients.
Researcher is looking for youth (ages 12-17) who have been diagnosed with celiac disease to participate in an online study
NFCA interviews the team behind a study focused on the prevalence of celiac disease in untested family members on Madeira Island.
In addition to gluten, researchers have found that the immune system of people with celiac disease react to specific types of non-gluten protein in wheat.
NFCA talked to researchers Tricia Thompson, MS, RD and Suzanne Simpson, RD, LD to get the answers.
New research suggests ongoing stomach trouble could be due to altered microbiota
Research Offers Benchmark of T Cell Reactivity by Comparing Side-by-Side Reactions to Barley and Oats in Celiac Disease Patients
The National Foundation for Celiac Awareness (NFCA) and The Jefferson Celiac Center at Thomas Jefferson University Hospitals want to learn more about the needs and experiences of those living with gluten-related disorders.
A clinical research study called the CeliAction Study is researching if an investigational drug – which would be taken as a supplement to an attempted gluten-free diet – improves any symptoms of celiac disease.
Study investigates a potential new treatment strategy for celiac disease - hookworms.
A clinical research study called the CeliAction Study is researching if an investigational drug – which would be taken as a supplement to an attempted gluten-free diet – improves any symptoms of celiac disease.
Along with genetics, researchers found that a child’s sex and country of residence are all associated with celiac disease prevalence.
A clinical research study called the CeliAction Study is researching if an investigational drug – which would be taken as a supplement to an attempted gluten-free diet – improves any symptoms of celiac disease.
This research aims to better understand the effect of income on the experiences of Americans with celiac disease.
A clinical research study called the CeliAction Study is researching if an investigational drug – which would be taken as a supplement to an attempted gluten-free diet – improves any symptoms of celiac disease.
People with celiac are needed to participate in a nationwide survey.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to